NCT05855863View on ClinicalTrials.gov

Clinical Study of GKT in Diabetes Related Dementia

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Dementia
Interventions
DRUG

Ginkgo Ketone Ester Tablets

Ginkgo Ketone Ester Tablets taken orally, 3 times a day, 0.5g each time, combined with conventional hypoglycemic treatment for six months

DRUG

placebo

placebo, taken orally, 3 times a day, 0.5g each time, combined with conventional hypoglycemic treatment for six months

All Listed Sponsors
lead

Shanghai 10th People's Hospital

OTHER